nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—attention deficit hyperactivity disorder—Clonidine—glaucoma	0.569	1	CpDpCtD
Methylphenidate—SLC6A2—Clonidine—glaucoma	0.0648	0.292	CbGbCtD
Methylphenidate—CYP2D6—Carteolol—glaucoma	0.0525	0.237	CbGbCtD
Methylphenidate—CYP2D6—Betaxolol—glaucoma	0.0355	0.16	CbGbCtD
Methylphenidate—CYP2D6—Methazolamide—glaucoma	0.0269	0.121	CbGbCtD
Methylphenidate—CYP2D6—Timolol—glaucoma	0.0228	0.103	CbGbCtD
Methylphenidate—CYP2D6—Clonidine—glaucoma	0.0194	0.0876	CbGbCtD
Methylphenidate—SLC6A3—Dopaminergic Neurogenesis—LMX1B—glaucoma	0.00145	0.0797	CbGpPWpGaD
Methylphenidate—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00107	0.0585	CbGpPWpGaD
Methylphenidate—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.000944	0.0518	CbGpPWpGaD
Methylphenidate—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.00078	0.0428	CbGpPWpGaD
Methylphenidate—SLC6A2—Amine compound SLC transporters—SLC6A13—glaucoma	0.000739	0.0406	CbGpPWpGaD
Methylphenidate—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.000691	0.0379	CbGpPWpGaD
Methylphenidate—SLC6A3—Amine compound SLC transporters—SLC6A13—glaucoma	0.000655	0.0359	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—ATOH7—glaucoma	0.000646	0.0355	CbGpPWpGaD
Methylphenidate—SLC6A4—Monoamine Transport—SLC6A1—glaucoma	0.000598	0.0328	CbGpPWpGaD
Methylphenidate—SLC6A2—Amine compound SLC transporters—SLC6A1—glaucoma	0.000541	0.0297	CbGpPWpGaD
Methylphenidate—SLC6A2—Monoamine Transport—SLC6A1—glaucoma	0.000514	0.0282	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00051	0.028	CbGpPWpGaD
Methylphenidate—SLC6A3—Amine compound SLC transporters—SLC6A1—glaucoma	0.000479	0.0263	CbGpPWpGaD
Methylphenidate—SLC6A3—Monoamine Transport—SLC6A1—glaucoma	0.000455	0.025	CbGpPWpGaD
Methylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000289	0.0159	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—OPN4—glaucoma	0.000257	0.0141	CbGpPWpGaD
Methylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000256	0.0141	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—SLC6A13—glaucoma	0.000242	0.0133	CbGpPWpGaD
Methylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000212	0.0116	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—SLC6A13—glaucoma	0.000208	0.0114	CbGpPWpGaD
Methylphenidate—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	0.000207	0.0114	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—TXN—glaucoma	0.000199	0.0109	CbGpPWpGaD
Methylphenidate—SLC6A3—Alpha-synuclein signaling—BAD—glaucoma	0.000198	0.0109	CbGpPWpGaD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000197	0.0108	CbGpPWpGaD
Methylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000187	0.0103	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—SLC6A13—glaucoma	0.000185	0.0101	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000183	0.01	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—SLC6A1—glaucoma	0.000177	0.00974	CbGpPWpGaD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000174	0.00957	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—TXN—glaucoma	0.000171	0.00939	CbGpPWpGaD
Methylphenidate—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	0.00016	0.00878	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—SLC6A1—glaucoma	0.000153	0.00837	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—TXN—glaucoma	0.000152	0.00832	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000148	0.00813	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—TGFB2—glaucoma	0.000145	0.00794	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000144	0.00788	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—SLC6A1—glaucoma	0.000135	0.00742	CbGpPWpGaD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000131	0.00721	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000131	0.0072	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000131	0.00718	CbGpPWpGaD
Methylphenidate—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	0.000129	0.0071	CbGpPWpGaD
Methylphenidate—SLC6A4—Monoamine Transport—TNF—glaucoma	0.000126	0.00692	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—TGFB2—glaucoma	0.000124	0.00683	CbGpPWpGaD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000116	0.00639	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—TGFB2—glaucoma	0.00011	0.00605	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—SLC6A13—glaucoma	0.00011	0.00604	CbGpPWpGaD
Methylphenidate—SLC6A2—Monoamine Transport—TNF—glaucoma	0.000108	0.00595	CbGpPWpGaD
Methylphenidate—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	0.000105	0.00577	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000105	0.00577	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.0001	0.00549	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—GSTM1—glaucoma	9.83e-05	0.0054	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—BDNF—glaucoma	9.77e-05	0.00536	CbGpPWpGaD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	9.62e-05	0.00528	CbGpPWpGaD
Methylphenidate—SLC6A3—Monoamine Transport—TNF—glaucoma	9.6e-05	0.00527	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL1A—glaucoma	9.38e-05	0.00515	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—NGFR—glaucoma	9.17e-05	0.00503	CbGpPWpGaD
Methylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.94e-05	0.00491	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC4A4—glaucoma	8.86e-05	0.00486	CbGpPWpGaD
Methylphenidate—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.82e-05	0.00484	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—NTRK1—glaucoma	8.71e-05	0.00478	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—NGF—glaucoma	8.67e-05	0.00476	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—NR3C1—glaucoma	8.63e-05	0.00473	CbGpPWpGaD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	8.52e-05	0.00467	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—GSTM1—glaucoma	8.46e-05	0.00464	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—SLC6A1—glaucoma	8.05e-05	0.00442	CbGpPWpGaD
Methylphenidate—Feeling abnormal—Travoprost—glaucoma	7.95e-05	0.000416	CcSEcCtD
Methylphenidate—Conjunctivitis—Timolol—glaucoma	7.92e-05	0.000415	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Dorzolamide—glaucoma	7.92e-05	0.000415	CcSEcCtD
Methylphenidate—Alopecia—Betaxolol—glaucoma	7.92e-05	0.000414	CcSEcCtD
Methylphenidate—Palpitations—Clonidine—glaucoma	7.91e-05	0.000414	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Pilocarpine—glaucoma	7.9e-05	0.000414	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Travoprost—glaucoma	7.89e-05	0.000413	CcSEcCtD
Methylphenidate—Loss of consciousness—Clonidine—glaucoma	7.87e-05	0.000412	CcSEcCtD
Methylphenidate—Feeling abnormal—Brinzolamide—glaucoma	7.85e-05	0.000411	CcSEcCtD
Methylphenidate—Mental disorder—Betaxolol—glaucoma	7.85e-05	0.000411	CcSEcCtD
Methylphenidate—Constipation—Pilocarpine—glaucoma	7.83e-05	0.00041	CcSEcCtD
Methylphenidate—Pain—Pilocarpine—glaucoma	7.83e-05	0.00041	CcSEcCtD
Methylphenidate—Cough—Clonidine—glaucoma	7.82e-05	0.000409	CcSEcCtD
Methylphenidate—Sweating—Timolol—glaucoma	7.81e-05	0.000409	CcSEcCtD
Methylphenidate—Dizziness—Apraclonidine—glaucoma	7.81e-05	0.000409	CcSEcCtD
Methylphenidate—Erythema—Betaxolol—glaucoma	7.8e-05	0.000408	CcSEcCtD
Methylphenidate—Malnutrition—Betaxolol—glaucoma	7.8e-05	0.000408	CcSEcCtD
Methylphenidate—Urticaria—Dorzolamide—glaucoma	7.7e-05	0.000403	CcSEcCtD
Methylphenidate—Epistaxis—Timolol—glaucoma	7.69e-05	0.000402	CcSEcCtD
Methylphenidate—Body temperature increased—Dorzolamide—glaucoma	7.66e-05	0.000401	CcSEcCtD
Methylphenidate—Abdominal pain—Dorzolamide—glaucoma	7.66e-05	0.000401	CcSEcCtD
Methylphenidate—Tension—Betaxolol—glaucoma	7.65e-05	0.000401	CcSEcCtD
Methylphenidate—Sinusitis—Timolol—glaucoma	7.65e-05	0.0004	CcSEcCtD
Methylphenidate—Arthralgia—Clonidine—glaucoma	7.63e-05	0.000399	CcSEcCtD
Methylphenidate—Chest pain—Clonidine—glaucoma	7.63e-05	0.000399	CcSEcCtD
Methylphenidate—Abdominal pain—Travoprost—glaucoma	7.62e-05	0.000399	CcSEcCtD
Methylphenidate—Anxiety—Clonidine—glaucoma	7.6e-05	0.000398	CcSEcCtD
Methylphenidate—Asthenia—Acetazolamide—glaucoma	7.58e-05	0.000397	CcSEcCtD
Methylphenidate—Dizziness—Bimatoprost—glaucoma	7.57e-05	0.000397	CcSEcCtD
Methylphenidate—Nervousness—Betaxolol—glaucoma	7.57e-05	0.000396	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	7.57e-05	0.000396	CcSEcCtD
Methylphenidate—Urticaria—Brinzolamide—glaucoma	7.57e-05	0.000396	CcSEcCtD
Methylphenidate—Feeling abnormal—Pilocarpine—glaucoma	7.54e-05	0.000395	CcSEcCtD
Methylphenidate—Discomfort—Clonidine—glaucoma	7.53e-05	0.000394	CcSEcCtD
Methylphenidate—Vomiting—Apraclonidine—glaucoma	7.51e-05	0.000393	CcSEcCtD
Methylphenidate—Muscle spasms—Betaxolol—glaucoma	7.5e-05	0.000392	CcSEcCtD
Methylphenidate—SLC6A3—NRF2 pathway—GSTM1—glaucoma	7.49e-05	0.00411	CbGpPWpGaD
Methylphenidate—Gastrointestinal pain—Pilocarpine—glaucoma	7.48e-05	0.000392	CcSEcCtD
Methylphenidate—Hypersensitivity—Brimonidine—glaucoma	7.47e-05	0.000391	CcSEcCtD
Methylphenidate—Dry mouth—Clonidine—glaucoma	7.46e-05	0.00039	CcSEcCtD
Methylphenidate—Bradycardia—Timolol—glaucoma	7.45e-05	0.00039	CcSEcCtD
Methylphenidate—Dermatitis—Apraclonidine—glaucoma	7.44e-05	0.00039	CcSEcCtD
Methylphenidate—Headache—Apraclonidine—glaucoma	7.4e-05	0.000387	CcSEcCtD
Methylphenidate—Confusional state—Clonidine—glaucoma	7.37e-05	0.000386	CcSEcCtD
Methylphenidate—Vision blurred—Betaxolol—glaucoma	7.35e-05	0.000385	CcSEcCtD
Methylphenidate—Rhinitis—Timolol—glaucoma	7.34e-05	0.000384	CcSEcCtD
Methylphenidate—Oedema—Clonidine—glaucoma	7.31e-05	0.000383	CcSEcCtD
Methylphenidate—Tremor—Betaxolol—glaucoma	7.31e-05	0.000382	CcSEcCtD
Methylphenidate—Hallucination—Timolol—glaucoma	7.28e-05	0.000381	CcSEcCtD
Methylphenidate—Asthenia—Brimonidine—glaucoma	7.28e-05	0.000381	CcSEcCtD
Methylphenidate—Infection—Clonidine—glaucoma	7.26e-05	0.00038	CcSEcCtD
Methylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.25e-05	0.00398	CbGpPWpGaD
Methylphenidate—Body temperature increased—Pilocarpine—glaucoma	7.24e-05	0.000379	CcSEcCtD
Methylphenidate—Abdominal pain—Pilocarpine—glaucoma	7.24e-05	0.000379	CcSEcCtD
Methylphenidate—Ill-defined disorder—Betaxolol—glaucoma	7.23e-05	0.000379	CcSEcCtD
Methylphenidate—Diarrhoea—Acetazolamide—glaucoma	7.23e-05	0.000379	CcSEcCtD
Methylphenidate—Rash—Bimatoprost—glaucoma	7.22e-05	0.000378	CcSEcCtD
Methylphenidate—Dermatitis—Bimatoprost—glaucoma	7.22e-05	0.000378	CcSEcCtD
Methylphenidate—Anaemia—Betaxolol—glaucoma	7.21e-05	0.000377	CcSEcCtD
Methylphenidate—Shock—Clonidine—glaucoma	7.19e-05	0.000376	CcSEcCtD
Methylphenidate—Connective tissue disorder—Timolol—glaucoma	7.19e-05	0.000376	CcSEcCtD
Methylphenidate—Pruritus—Brimonidine—glaucoma	7.18e-05	0.000376	CcSEcCtD
Methylphenidate—Headache—Bimatoprost—glaucoma	7.18e-05	0.000376	CcSEcCtD
Methylphenidate—Nervous system disorder—Clonidine—glaucoma	7.17e-05	0.000375	CcSEcCtD
Methylphenidate—Thrombocytopenia—Clonidine—glaucoma	7.16e-05	0.000375	CcSEcCtD
Methylphenidate—Hypersensitivity—Dorzolamide—glaucoma	7.14e-05	0.000374	CcSEcCtD
Methylphenidate—Tachycardia—Clonidine—glaucoma	7.13e-05	0.000373	CcSEcCtD
Methylphenidate—Hypersensitivity—Travoprost—glaucoma	7.11e-05	0.000372	CcSEcCtD
Methylphenidate—Skin disorder—Clonidine—glaucoma	7.1e-05	0.000372	CcSEcCtD
Methylphenidate—Hyperhidrosis—Clonidine—glaucoma	7.07e-05	0.00037	CcSEcCtD
Methylphenidate—Visual impairment—Timolol—glaucoma	7.05e-05	0.000369	CcSEcCtD
Methylphenidate—Malaise—Betaxolol—glaucoma	7.03e-05	0.000368	CcSEcCtD
Methylphenidate—Nausea—Apraclonidine—glaucoma	7.02e-05	0.000367	CcSEcCtD
Methylphenidate—Hypersensitivity—Brinzolamide—glaucoma	7.02e-05	0.000367	CcSEcCtD
Methylphenidate—Vertigo—Betaxolol—glaucoma	7.01e-05	0.000367	CcSEcCtD
Methylphenidate—Syncope—Betaxolol—glaucoma	6.99e-05	0.000366	CcSEcCtD
Methylphenidate—Dizziness—Acetazolamide—glaucoma	6.99e-05	0.000366	CcSEcCtD
Methylphenidate—Anorexia—Clonidine—glaucoma	6.97e-05	0.000365	CcSEcCtD
Methylphenidate—Asthenia—Dorzolamide—glaucoma	6.95e-05	0.000364	CcSEcCtD
Methylphenidate—Asthenia—Travoprost—glaucoma	6.92e-05	0.000362	CcSEcCtD
Methylphenidate—Palpitations—Betaxolol—glaucoma	6.89e-05	0.000361	CcSEcCtD
Methylphenidate—Pruritus—Dorzolamide—glaucoma	6.85e-05	0.000359	CcSEcCtD
Methylphenidate—Loss of consciousness—Betaxolol—glaucoma	6.85e-05	0.000359	CcSEcCtD
Methylphenidate—Eye disorder—Timolol—glaucoma	6.84e-05	0.000358	CcSEcCtD
Methylphenidate—Asthenia—Brinzolamide—glaucoma	6.83e-05	0.000358	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—FAS—glaucoma	6.83e-05	0.00375	CbGpPWpGaD
Methylphenidate—Pruritus—Travoprost—glaucoma	6.82e-05	0.000357	CcSEcCtD
Methylphenidate—Cough—Betaxolol—glaucoma	6.8e-05	0.000356	CcSEcCtD
Methylphenidate—Nausea—Bimatoprost—glaucoma	6.8e-05	0.000356	CcSEcCtD
Methylphenidate—Cardiac disorder—Timolol—glaucoma	6.79e-05	0.000356	CcSEcCtD
Methylphenidate—Hypersensitivity—Pilocarpine—glaucoma	6.74e-05	0.000353	CcSEcCtD
Methylphenidate—Pruritus—Brinzolamide—glaucoma	6.74e-05	0.000353	CcSEcCtD
Methylphenidate—Vomiting—Acetazolamide—glaucoma	6.72e-05	0.000352	CcSEcCtD
Methylphenidate—Dizziness—Brimonidine—glaucoma	6.71e-05	0.000351	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.68e-05	0.00366	CbGpPWpGaD
Methylphenidate—Musculoskeletal discomfort—Clonidine—glaucoma	6.66e-05	0.000349	CcSEcCtD
Methylphenidate—Angiopathy—Timolol—glaucoma	6.64e-05	0.000348	CcSEcCtD
Methylphenidate—Arthralgia—Betaxolol—glaucoma	6.64e-05	0.000348	CcSEcCtD
Methylphenidate—Myalgia—Betaxolol—glaucoma	6.64e-05	0.000348	CcSEcCtD
Methylphenidate—Chest pain—Betaxolol—glaucoma	6.64e-05	0.000348	CcSEcCtD
Methylphenidate—Diarrhoea—Dorzolamide—glaucoma	6.63e-05	0.000347	CcSEcCtD
Methylphenidate—Headache—Acetazolamide—glaucoma	6.62e-05	0.000347	CcSEcCtD
Methylphenidate—Anxiety—Betaxolol—glaucoma	6.62e-05	0.000346	CcSEcCtD
Methylphenidate—Insomnia—Clonidine—glaucoma	6.61e-05	0.000346	CcSEcCtD
Methylphenidate—Immune system disorder—Timolol—glaucoma	6.61e-05	0.000346	CcSEcCtD
Methylphenidate—Diarrhoea—Travoprost—glaucoma	6.6e-05	0.000345	CcSEcCtD
Methylphenidate—Mediastinal disorder—Timolol—glaucoma	6.59e-05	0.000345	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	6.59e-05	0.000345	CcSEcCtD
Methylphenidate—Asthenia—Pilocarpine—glaucoma	6.57e-05	0.000344	CcSEcCtD
Methylphenidate—Paraesthesia—Clonidine—glaucoma	6.56e-05	0.000344	CcSEcCtD
Methylphenidate—Discomfort—Betaxolol—glaucoma	6.56e-05	0.000343	CcSEcCtD
Methylphenidate—Arrhythmia—Timolol—glaucoma	6.54e-05	0.000342	CcSEcCtD
Methylphenidate—Dyspnoea—Clonidine—glaucoma	6.52e-05	0.000341	CcSEcCtD
Methylphenidate—Diarrhoea—Brinzolamide—glaucoma	6.52e-05	0.000341	CcSEcCtD
Methylphenidate—Somnolence—Clonidine—glaucoma	6.5e-05	0.00034	CcSEcCtD
Methylphenidate—Dry mouth—Betaxolol—glaucoma	6.49e-05	0.00034	CcSEcCtD
Methylphenidate—Pruritus—Pilocarpine—glaucoma	6.48e-05	0.000339	CcSEcCtD
Methylphenidate—Alopecia—Timolol—glaucoma	6.47e-05	0.000338	CcSEcCtD
Methylphenidate—Confusional state—Betaxolol—glaucoma	6.42e-05	0.000336	CcSEcCtD
Methylphenidate—Mental disorder—Timolol—glaucoma	6.41e-05	0.000336	CcSEcCtD
Methylphenidate—Dizziness—Dorzolamide—glaucoma	6.41e-05	0.000335	CcSEcCtD
Methylphenidate—Rash—Brimonidine—glaucoma	6.4e-05	0.000335	CcSEcCtD
Methylphenidate—Dermatitis—Brimonidine—glaucoma	6.39e-05	0.000334	CcSEcCtD
Methylphenidate—Dizziness—Travoprost—glaucoma	6.38e-05	0.000334	CcSEcCtD
Methylphenidate—Erythema—Timolol—glaucoma	6.37e-05	0.000333	CcSEcCtD
Methylphenidate—Malnutrition—Timolol—glaucoma	6.37e-05	0.000333	CcSEcCtD
Methylphenidate—Oedema—Betaxolol—glaucoma	6.36e-05	0.000333	CcSEcCtD
Methylphenidate—Headache—Brimonidine—glaucoma	6.35e-05	0.000333	CcSEcCtD
Methylphenidate—Decreased appetite—Clonidine—glaucoma	6.35e-05	0.000333	CcSEcCtD
Methylphenidate—Infection—Betaxolol—glaucoma	6.32e-05	0.000331	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Clonidine—glaucoma	6.31e-05	0.00033	CcSEcCtD
Methylphenidate—Fatigue—Clonidine—glaucoma	6.3e-05	0.00033	CcSEcCtD
Methylphenidate—Dizziness—Brinzolamide—glaucoma	6.3e-05	0.00033	CcSEcCtD
Methylphenidate—Nausea—Acetazolamide—glaucoma	6.28e-05	0.000329	CcSEcCtD
Methylphenidate—Diarrhoea—Pilocarpine—glaucoma	6.26e-05	0.000328	CcSEcCtD
Methylphenidate—Shock—Betaxolol—glaucoma	6.26e-05	0.000328	CcSEcCtD
Methylphenidate—Tension—Timolol—glaucoma	6.25e-05	0.000327	CcSEcCtD
Methylphenidate—Pain—Clonidine—glaucoma	6.25e-05	0.000327	CcSEcCtD
Methylphenidate—Constipation—Clonidine—glaucoma	6.25e-05	0.000327	CcSEcCtD
Methylphenidate—Nervous system disorder—Betaxolol—glaucoma	6.24e-05	0.000327	CcSEcCtD
Methylphenidate—Thrombocytopenia—Betaxolol—glaucoma	6.23e-05	0.000326	CcSEcCtD
Methylphenidate—Tachycardia—Betaxolol—glaucoma	6.21e-05	0.000325	CcSEcCtD
Methylphenidate—Nervousness—Timolol—glaucoma	6.19e-05	0.000324	CcSEcCtD
Methylphenidate—Skin disorder—Betaxolol—glaucoma	6.18e-05	0.000324	CcSEcCtD
Methylphenidate—Vomiting—Dorzolamide—glaucoma	6.16e-05	0.000322	CcSEcCtD
Methylphenidate—Hyperhidrosis—Betaxolol—glaucoma	6.15e-05	0.000322	CcSEcCtD
Methylphenidate—Rash—Dorzolamide—glaucoma	6.11e-05	0.00032	CcSEcCtD
Methylphenidate—Dermatitis—Dorzolamide—glaucoma	6.1e-05	0.000319	CcSEcCtD
Methylphenidate—Rash—Travoprost—glaucoma	6.08e-05	0.000318	CcSEcCtD
Methylphenidate—Dermatitis—Travoprost—glaucoma	6.08e-05	0.000318	CcSEcCtD
Methylphenidate—Headache—Dorzolamide—glaucoma	6.07e-05	0.000318	CcSEcCtD
Methylphenidate—Anorexia—Betaxolol—glaucoma	6.07e-05	0.000318	CcSEcCtD
Methylphenidate—Vomiting—Brinzolamide—glaucoma	6.06e-05	0.000317	CcSEcCtD
Methylphenidate—Dizziness—Pilocarpine—glaucoma	6.05e-05	0.000317	CcSEcCtD
Methylphenidate—Headache—Travoprost—glaucoma	6.04e-05	0.000316	CcSEcCtD
Methylphenidate—Nausea—Brimonidine—glaucoma	6.02e-05	0.000315	CcSEcCtD
Methylphenidate—Feeling abnormal—Clonidine—glaucoma	6.02e-05	0.000315	CcSEcCtD
Methylphenidate—Rash—Brinzolamide—glaucoma	6e-05	0.000314	CcSEcCtD
Methylphenidate—Vision blurred—Timolol—glaucoma	6e-05	0.000314	CcSEcCtD
Methylphenidate—Dermatitis—Brinzolamide—glaucoma	6e-05	0.000314	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Clonidine—glaucoma	5.98e-05	0.000313	CcSEcCtD
Methylphenidate—Headache—Brinzolamide—glaucoma	5.97e-05	0.000312	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.91e-05	0.00325	CbGpPWpGaD
Methylphenidate—Angioedema—Timolol—glaucoma	5.82e-05	0.000305	CcSEcCtD
Methylphenidate—Vomiting—Pilocarpine—glaucoma	5.82e-05	0.000305	CcSEcCtD
Methylphenidate—Urticaria—Clonidine—glaucoma	5.81e-05	0.000304	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Betaxolol—glaucoma	5.8e-05	0.000304	CcSEcCtD
Methylphenidate—Body temperature increased—Clonidine—glaucoma	5.78e-05	0.000302	CcSEcCtD
Methylphenidate—Abdominal pain—Clonidine—glaucoma	5.78e-05	0.000302	CcSEcCtD
Methylphenidate—Rash—Pilocarpine—glaucoma	5.77e-05	0.000302	CcSEcCtD
Methylphenidate—Dermatitis—Pilocarpine—glaucoma	5.77e-05	0.000302	CcSEcCtD
Methylphenidate—Insomnia—Betaxolol—glaucoma	5.76e-05	0.000301	CcSEcCtD
Methylphenidate—Nausea—Dorzolamide—glaucoma	5.75e-05	0.000301	CcSEcCtD
Methylphenidate—Headache—Pilocarpine—glaucoma	5.73e-05	0.0003	CcSEcCtD
Methylphenidate—Nausea—Travoprost—glaucoma	5.73e-05	0.0003	CcSEcCtD
Methylphenidate—Vertigo—Timolol—glaucoma	5.72e-05	0.0003	CcSEcCtD
Methylphenidate—Paraesthesia—Betaxolol—glaucoma	5.71e-05	0.000299	CcSEcCtD
Methylphenidate—Syncope—Timolol—glaucoma	5.71e-05	0.000299	CcSEcCtD
Methylphenidate—Dyspnoea—Betaxolol—glaucoma	5.67e-05	0.000297	CcSEcCtD
Methylphenidate—Nausea—Brinzolamide—glaucoma	5.66e-05	0.000296	CcSEcCtD
Methylphenidate—Palpitations—Timolol—glaucoma	5.63e-05	0.000295	CcSEcCtD
Methylphenidate—Dyspepsia—Betaxolol—glaucoma	5.6e-05	0.000293	CcSEcCtD
Methylphenidate—Loss of consciousness—Timolol—glaucoma	5.6e-05	0.000293	CcSEcCtD
Methylphenidate—Cough—Timolol—glaucoma	5.56e-05	0.000291	CcSEcCtD
Methylphenidate—Decreased appetite—Betaxolol—glaucoma	5.53e-05	0.00029	CcSEcCtD
Methylphenidate—Hypertension—Timolol—glaucoma	5.5e-05	0.000288	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Betaxolol—glaucoma	5.49e-05	0.000288	CcSEcCtD
Methylphenidate—Fatigue—Betaxolol—glaucoma	5.49e-05	0.000287	CcSEcCtD
Methylphenidate—Constipation—Betaxolol—glaucoma	5.44e-05	0.000285	CcSEcCtD
Methylphenidate—Pain—Betaxolol—glaucoma	5.44e-05	0.000285	CcSEcCtD
Methylphenidate—Nausea—Pilocarpine—glaucoma	5.44e-05	0.000285	CcSEcCtD
Methylphenidate—Myalgia—Timolol—glaucoma	5.42e-05	0.000284	CcSEcCtD
Methylphenidate—Chest pain—Timolol—glaucoma	5.42e-05	0.000284	CcSEcCtD
Methylphenidate—Arthralgia—Timolol—glaucoma	5.42e-05	0.000284	CcSEcCtD
Methylphenidate—Anxiety—Timolol—glaucoma	5.4e-05	0.000283	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	5.39e-05	0.000282	CcSEcCtD
Methylphenidate—Hypersensitivity—Clonidine—glaucoma	5.39e-05	0.000282	CcSEcCtD
Methylphenidate—Discomfort—Timolol—glaucoma	5.36e-05	0.00028	CcSEcCtD
Methylphenidate—Dry mouth—Timolol—glaucoma	5.3e-05	0.000278	CcSEcCtD
Methylphenidate—Asthenia—Clonidine—glaucoma	5.24e-05	0.000275	CcSEcCtD
Methylphenidate—Feeling abnormal—Betaxolol—glaucoma	5.24e-05	0.000275	CcSEcCtD
Methylphenidate—Confusional state—Timolol—glaucoma	5.24e-05	0.000274	CcSEcCtD
Methylphenidate—Anaphylactic shock—Timolol—glaucoma	5.2e-05	0.000272	CcSEcCtD
Methylphenidate—Oedema—Timolol—glaucoma	5.2e-05	0.000272	CcSEcCtD
Methylphenidate—Pruritus—Clonidine—glaucoma	5.17e-05	0.000271	CcSEcCtD
Methylphenidate—Infection—Timolol—glaucoma	5.16e-05	0.00027	CcSEcCtD
Methylphenidate—Shock—Timolol—glaucoma	5.11e-05	0.000268	CcSEcCtD
Methylphenidate—Nervous system disorder—Timolol—glaucoma	5.1e-05	0.000267	CcSEcCtD
Methylphenidate—Urticaria—Betaxolol—glaucoma	5.06e-05	0.000265	CcSEcCtD
Methylphenidate—Skin disorder—Timolol—glaucoma	5.05e-05	0.000264	CcSEcCtD
Methylphenidate—Body temperature increased—Betaxolol—glaucoma	5.03e-05	0.000263	CcSEcCtD
Methylphenidate—Hyperhidrosis—Timolol—glaucoma	5.03e-05	0.000263	CcSEcCtD
Methylphenidate—Diarrhoea—Clonidine—glaucoma	5e-05	0.000262	CcSEcCtD
Methylphenidate—Anorexia—Timolol—glaucoma	4.96e-05	0.000259	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.89e-05	0.00268	CbGpPWpGaD
Methylphenidate—Dizziness—Clonidine—glaucoma	4.83e-05	0.000253	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—GSTT1—glaucoma	4.83e-05	0.00265	CbGpPWpGaD
Methylphenidate—Musculoskeletal discomfort—Timolol—glaucoma	4.74e-05	0.000248	CcSEcCtD
Methylphenidate—Insomnia—Timolol—glaucoma	4.7e-05	0.000246	CcSEcCtD
Methylphenidate—Hypersensitivity—Betaxolol—glaucoma	4.69e-05	0.000245	CcSEcCtD
Methylphenidate—Paraesthesia—Timolol—glaucoma	4.67e-05	0.000244	CcSEcCtD
Methylphenidate—Vomiting—Clonidine—glaucoma	4.65e-05	0.000243	CcSEcCtD
Methylphenidate—Dyspnoea—Timolol—glaucoma	4.63e-05	0.000243	CcSEcCtD
Methylphenidate—Somnolence—Timolol—glaucoma	4.62e-05	0.000242	CcSEcCtD
Methylphenidate—Rash—Clonidine—glaucoma	4.61e-05	0.000241	CcSEcCtD
Methylphenidate—Dermatitis—Clonidine—glaucoma	4.6e-05	0.000241	CcSEcCtD
Methylphenidate—Headache—Clonidine—glaucoma	4.58e-05	0.00024	CcSEcCtD
Methylphenidate—Dyspepsia—Timolol—glaucoma	4.58e-05	0.00024	CcSEcCtD
Methylphenidate—Asthenia—Betaxolol—glaucoma	4.57e-05	0.000239	CcSEcCtD
Methylphenidate—Decreased appetite—Timolol—glaucoma	4.52e-05	0.000237	CcSEcCtD
Methylphenidate—Pruritus—Betaxolol—glaucoma	4.5e-05	0.000236	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Timolol—glaucoma	4.49e-05	0.000235	CcSEcCtD
Methylphenidate—Fatigue—Timolol—glaucoma	4.48e-05	0.000235	CcSEcCtD
Methylphenidate—Pain—Timolol—glaucoma	4.45e-05	0.000233	CcSEcCtD
Methylphenidate—Diarrhoea—Betaxolol—glaucoma	4.35e-05	0.000228	CcSEcCtD
Methylphenidate—Nausea—Clonidine—glaucoma	4.34e-05	0.000227	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.33e-05	0.00238	CbGpPWpGaD
Methylphenidate—Feeling abnormal—Timolol—glaucoma	4.28e-05	0.000224	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Timolol—glaucoma	4.25e-05	0.000223	CcSEcCtD
Methylphenidate—Dizziness—Betaxolol—glaucoma	4.21e-05	0.00022	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—VEGFA—glaucoma	4.14e-05	0.00227	CbGpPWpGaD
Methylphenidate—Urticaria—Timolol—glaucoma	4.13e-05	0.000216	CcSEcCtD
Methylphenidate—Body temperature increased—Timolol—glaucoma	4.11e-05	0.000215	CcSEcCtD
Methylphenidate—Abdominal pain—Timolol—glaucoma	4.11e-05	0.000215	CcSEcCtD
Methylphenidate—Vomiting—Betaxolol—glaucoma	4.05e-05	0.000212	CcSEcCtD
Methylphenidate—Rash—Betaxolol—glaucoma	4.01e-05	0.00021	CcSEcCtD
Methylphenidate—Dermatitis—Betaxolol—glaucoma	4.01e-05	0.00021	CcSEcCtD
Methylphenidate—Headache—Betaxolol—glaucoma	3.99e-05	0.000209	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—CYP1B1—glaucoma	3.85e-05	0.00211	CbGpPWpGaD
Methylphenidate—Hypersensitivity—Timolol—glaucoma	3.83e-05	0.000201	CcSEcCtD
Methylphenidate—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	3.8e-05	0.00208	CbGpPWpGaD
Methylphenidate—Nausea—Betaxolol—glaucoma	3.78e-05	0.000198	CcSEcCtD
Methylphenidate—Asthenia—Timolol—glaucoma	3.73e-05	0.000195	CcSEcCtD
Methylphenidate—Pruritus—Timolol—glaucoma	3.68e-05	0.000193	CcSEcCtD
Methylphenidate—Diarrhoea—Timolol—glaucoma	3.56e-05	0.000186	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—TNF—glaucoma	3.55e-05	0.00195	CbGpPWpGaD
Methylphenidate—Dizziness—Timolol—glaucoma	3.44e-05	0.00018	CcSEcCtD
Methylphenidate—CYP2D6—Metabolism—CA5A—glaucoma	3.39e-05	0.00186	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—NARFL—glaucoma	3.39e-05	0.00186	CbGpPWpGaD
Methylphenidate—Vomiting—Timolol—glaucoma	3.31e-05	0.000173	CcSEcCtD
Methylphenidate—Rash—Timolol—glaucoma	3.28e-05	0.000172	CcSEcCtD
Methylphenidate—Dermatitis—Timolol—glaucoma	3.27e-05	0.000171	CcSEcCtD
Methylphenidate—Headache—Timolol—glaucoma	3.26e-05	0.00017	CcSEcCtD
Methylphenidate—Nausea—Timolol—glaucoma	3.09e-05	0.000162	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—GSTM1—glaucoma	3.08e-05	0.00169	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	3.04e-05	0.00167	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—TP53—glaucoma	2.55e-05	0.0014	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CA1—glaucoma	1.65e-05	0.000907	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CTSA—glaucoma	1.6e-05	0.000879	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CA2—glaucoma	1.51e-05	0.00083	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—TXN—glaucoma	1.07e-05	0.000585	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GSTT1—glaucoma	8.26e-06	0.000453	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ABCA1—glaucoma	6.58e-06	0.000361	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CYP1B1—glaucoma	6.58e-06	0.000361	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GSTM1—glaucoma	5.26e-06	0.000289	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—MTHFR—glaucoma	4.65e-06	0.000255	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—APOE—glaucoma	4.33e-06	0.000238	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CAV1—glaucoma	4.29e-06	0.000235	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—NOS3—glaucoma	3.24e-06	0.000178	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PTGS2—glaucoma	2.97e-06	0.000163	CbGpPWpGaD
